Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial.

Saved in:
Bibliographic Details
Title: Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial.
Authors: Martin-Broto J; Medical Oncology Department, University Hospital Fundación Jimenez Diaz, Madrid, Spain. jmartin@mustbesevilla.org.; University Hospital General de Villalba, Madrid, Spain.; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain., Lopez-Alvarez M; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain., Moura DS; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain., Ramos R; Pathology Department, University Hospital Son Espases, Mallorca, Spain., Collini P; Soft Tissue and Bone Pathology, Histopathology and Pediatric Pathology Unit, Diagnostic Pathology and Laboratory Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale Tumori, Milan, Italy., Romagosa C; Pathology Department, University Hospital Vall D'Hebron, Barcelona, Spain.; Centro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Bagué S; Pathology Department, Santa Creu I Sant Pau Hospital, Barcelona, Spain., Renne SL; Anatomic Pathology Unit, Humanitas Clinical and Research Center - IRCCS -, Rozzano (MI), Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy., Barisella M; Soft Tissue and Bone Pathology, Histopathology and Pediatric Pathology Unit, Diagnostic Pathology and Laboratory Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale Tumori, Milan, Italy., Velasco V; Pathology Department, Service d'Anatomie Pathologique, Institut Bergonié, Bordeaux, France., Coindre JM; Bergonie Institute, Department of Biopathology, Bordeaux, and Bordeaux University, Talence, France., Lopez-Lopez D; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain.; Clinical Bioinformatics Area. Fundación Progreso y Salud (FPS). CDCA, Hospital Virgen del Rocio, Sevilla, Spain.; Bioinformatics in Rare Diseases (BiER). Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, Sevilla, Spain., Dopazo J; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain.; Clinical Bioinformatics Area. Fundación Progreso y Salud (FPS). CDCA, Hospital Virgen del Rocio, Sevilla, Spain.; Bioinformatics in Rare Diseases (BiER). Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, Sevilla, Spain.; INB-ELIXIR-es FPS, Hospital Virgen del Rocío, Sevilla, Spain., Gambarotti M; Department of Anatomy and Pathological Histology, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy., Braglia L; Research and Statistics Infrastructure, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy., Merlo DF; Research and Statistics Infrastructure, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy., Palmerini E; Chemotherapy Unit, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy., Stacchiotti S; Cancer Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy., Quagliuolo VL; Department of Surgery, Istituto Clinico Humanitas, Rozzano, Italy., Lopez-Pousa A; Medical Oncology Department, Santa Creu I Sant Pau Hospital, Barcelona, Spain., Grignani G; Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Blay JY; Department of Medical Oncology, Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France., Brunello A; Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV, IRCCS, Padova, Italy., Gutierrez A; Hematology Department, Son Espases University Hospital, Mallorca, Spain., Valverde C; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Hindi N; Medical Oncology Department, University Hospital Fundación Jimenez Diaz, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain.; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain., Dei Tos AP; Department of Pathology, Treviso General Hospital, Treviso, Italy.; University of Padua, Padova, Italy., Picci P; Laboratory of Oncologic Research, Istituto Ortopedico Rizzoli, Bologna, Italy., Casali PG; Cancer Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2021 Dec; Vol. 20 (12), pp. 2539-2552. Date of Electronic Publication: 2021 Sep 22.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34552008
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martin-Broto+J%22">Martin-Broto J</searchLink>; Medical Oncology Department, University Hospital Fundación Jimenez Diaz, Madrid, Spain. jmartin@mustbesevilla.org.; University Hospital General de Villalba, Madrid, Spain.; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lopez-Alvarez+M%22">Lopez-Alvarez M</searchLink>; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Moura+DS%22">Moura DS</searchLink>; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Ramos+R%22">Ramos R</searchLink>; Pathology Department, University Hospital Son Espases, Mallorca, Spain.<br /><searchLink fieldCode="AU" term="%22Collini+P%22">Collini P</searchLink>; Soft Tissue and Bone Pathology, Histopathology and Pediatric Pathology Unit, Diagnostic Pathology and Laboratory Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Romagosa+C%22">Romagosa C</searchLink>; Pathology Department, University Hospital Vall D'Hebron, Barcelona, Spain.; Centro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bagué+S%22">Bagué S</searchLink>; Pathology Department, Santa Creu I Sant Pau Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Renne+SL%22">Renne SL</searchLink>; Anatomic Pathology Unit, Humanitas Clinical and Research Center - IRCCS -, Rozzano (MI), Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.<br /><searchLink fieldCode="AU" term="%22Barisella+M%22">Barisella M</searchLink>; Soft Tissue and Bone Pathology, Histopathology and Pediatric Pathology Unit, Diagnostic Pathology and Laboratory Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Velasco+V%22">Velasco V</searchLink>; Pathology Department, Service d'Anatomie Pathologique, Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Coindre+JM%22">Coindre JM</searchLink>; Bergonie Institute, Department of Biopathology, Bordeaux, and Bordeaux University, Talence, France.<br /><searchLink fieldCode="AU" term="%22Lopez-Lopez+D%22">Lopez-Lopez D</searchLink>; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain.; Clinical Bioinformatics Area. Fundación Progreso y Salud (FPS). CDCA, Hospital Virgen del Rocio, Sevilla, Spain.; Bioinformatics in Rare Diseases (BiER). Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Dopazo+J%22">Dopazo J</searchLink>; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain.; Clinical Bioinformatics Area. Fundación Progreso y Salud (FPS). CDCA, Hospital Virgen del Rocio, Sevilla, Spain.; Bioinformatics in Rare Diseases (BiER). Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, Sevilla, Spain.; INB-ELIXIR-es FPS, Hospital Virgen del Rocío, Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Gambarotti+M%22">Gambarotti M</searchLink>; Department of Anatomy and Pathological Histology, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Braglia+L%22">Braglia L</searchLink>; Research and Statistics Infrastructure, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.<br /><searchLink fieldCode="AU" term="%22Merlo+DF%22">Merlo DF</searchLink>; Research and Statistics Infrastructure, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.<br /><searchLink fieldCode="AU" term="%22Palmerini+E%22">Palmerini E</searchLink>; Chemotherapy Unit, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Stacchiotti+S%22">Stacchiotti S</searchLink>; Cancer Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Quagliuolo+VL%22">Quagliuolo VL</searchLink>; Department of Surgery, Istituto Clinico Humanitas, Rozzano, Italy.<br /><searchLink fieldCode="AU" term="%22Lopez-Pousa+A%22">Lopez-Pousa A</searchLink>; Medical Oncology Department, Santa Creu I Sant Pau Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Grignani+G%22">Grignani G</searchLink>; Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.<br /><searchLink fieldCode="AU" term="%22Blay+JY%22">Blay JY</searchLink>; Department of Medical Oncology, Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Brunello+A%22">Brunello A</searchLink>; Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV, IRCCS, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Gutierrez+A%22">Gutierrez A</searchLink>; Hematology Department, Son Espases University Hospital, Mallorca, Spain.<br /><searchLink fieldCode="AU" term="%22Valverde+C%22">Valverde C</searchLink>; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Hindi+N%22">Hindi N</searchLink>; Medical Oncology Department, University Hospital Fundación Jimenez Diaz, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain.; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Dei+Tos+AP%22">Dei Tos AP</searchLink>; Department of Pathology, Treviso General Hospital, Treviso, Italy.; University of Padua, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Picci+P%22">Picci P</searchLink>; Laboratory of Oncologic Research, Istituto Ortopedico Rizzoli, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Casali+PG%22">Casali PG</searchLink>; Cancer Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Gronchi+A%22">Gronchi A</searchLink>; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2021 Dec; Vol. 20 (12), pp. 2539-2552. <i>Date of Electronic Publication: </i>2021 Sep 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34552008
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-21-0315
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2539
    Titles:
      – TitleFull: Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martin-Broto J
      – PersonEntity:
          Name:
            NameFull: Lopez-Alvarez M
      – PersonEntity:
          Name:
            NameFull: Moura DS
      – PersonEntity:
          Name:
            NameFull: Ramos R
      – PersonEntity:
          Name:
            NameFull: Collini P
      – PersonEntity:
          Name:
            NameFull: Romagosa C
      – PersonEntity:
          Name:
            NameFull: Bagué S
      – PersonEntity:
          Name:
            NameFull: Renne SL
      – PersonEntity:
          Name:
            NameFull: Barisella M
      – PersonEntity:
          Name:
            NameFull: Velasco V
      – PersonEntity:
          Name:
            NameFull: Coindre JM
      – PersonEntity:
          Name:
            NameFull: Lopez-Lopez D
      – PersonEntity:
          Name:
            NameFull: Dopazo J
      – PersonEntity:
          Name:
            NameFull: Gambarotti M
      – PersonEntity:
          Name:
            NameFull: Braglia L
      – PersonEntity:
          Name:
            NameFull: Merlo DF
      – PersonEntity:
          Name:
            NameFull: Palmerini E
      – PersonEntity:
          Name:
            NameFull: Stacchiotti S
      – PersonEntity:
          Name:
            NameFull: Quagliuolo VL
      – PersonEntity:
          Name:
            NameFull: Lopez-Pousa A
      – PersonEntity:
          Name:
            NameFull: Grignani G
      – PersonEntity:
          Name:
            NameFull: Blay JY
      – PersonEntity:
          Name:
            NameFull: Brunello A
      – PersonEntity:
          Name:
            NameFull: Gutierrez A
      – PersonEntity:
          Name:
            NameFull: Valverde C
      – PersonEntity:
          Name:
            NameFull: Hindi N
      – PersonEntity:
          Name:
            NameFull: Dei Tos AP
      – PersonEntity:
          Name:
            NameFull: Picci P
      – PersonEntity:
          Name:
            NameFull: Casali PG
      – PersonEntity:
          Name:
            NameFull: Gronchi A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2021 Dec
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1